Aoe K - Search Results

1

The impact of epidermal growth factor receptor gene status on gefitinib-treated Japanese patients with non-small-cell lung cancer.

Ichihara S, Toyooka S, Fujiwara Y, Hotta K, Shigematsu H, Tokumo M, Soh J, Asano H, Ichimura K, Aoe K, Aoe M, Kiura K, Shimizu K, Date H, Shimizu N. Ichihara S, et al. Among authors: aoe k, aoe m. Int J Cancer. 2007 Mar 15;120(6):1239-47. doi: 10.1002/ijc.22513. Int J Cancer. 2007. PMID: 17192902

2

An alteration of ganglioside composition in cisplatin-resistant lung cancer cell line.

Kiura K, Watarai S, Ueoka H, Tabata M, Gemba K, Aoe K, Yamane H, Yasuda T, Harada M. Kiura K, et al. Among authors: aoe k. Anticancer Res. 1998 Jul-Aug;18(4C):2957-60. Anticancer Res. 1998. PMID: 9713491

3

Effect of docetaxel with cisplatin or vinorelbine on lung cancer cell lines.

Aoe K, Kiura K, Ueoka H, Tabata M, Matsumura T, Chikamori M, Matsushita A, Kohara H, Harada M. Aoe K, et al. Anticancer Res. 1999 Jan-Feb;19(1A):291-9. Anticancer Res. 1999. PMID: 10226557

4

Establishment of a drug sensitivity panel using human lung cancer cell lines.

Matsushita A, Tabata M, Ueoka H, Kiura K, Shibayama T, Aoe K, Kohara H, Harada M. Matsushita A, et al. Among authors: aoe k. Acta Med Okayama. 1999 Apr;53(2):67-75. doi: 10.18926/AMO/31626. Acta Med Okayama. 1999. PMID: 10358721

5

In vitro evaluation of antimicrotubule agents in human small-cell lung cancer cell lines.

Ikubo S, Takigawa N, Ueoka H, Kiura K, Tabata M, Shibayama T, Chikamori M, Aoe K, Matsushita A, Harada M. Ikubo S, et al. Among authors: aoe k. Anticancer Res. 1999 Sep-Oct;19(5B):3985-8. Anticancer Res. 1999. PMID: 10628341

6

Synergistic effects of topoisomerase I inhibitor, 7-ethyl-10-hydroxycamptothecin, and irradiation in a cisplatin-resistant human small cell lung cancer cell line.

Kohara H, Tabata M, Kiura K, Ueoka H, Kawata K, Chikamori M, Aoe K, Chikamori K, Matsushita A, Harada M. Kohara H, et al. Among authors: aoe k. Clin Cancer Res. 2002 Jan;8(1):287-92. Clin Cancer Res. 2002. PMID: 11801571

7

[Combination chemotherapy with carboplatin and etoposide for elderly patients aged 76 years or older with small cell lung cancer].

Tada A, Ueoka H, Kiura K, Tabata M, Takemoto M, Yamane H, Hiyama J, Aoe K, Shibayama T, Kamei H, Kawahara S, Harita S, Sato T, Kobayashi M, Eguchi K, Hiraki S, Hiraki Y, Tanimoto M. Tada A, et al. Among authors: aoe k. Gan To Kagaku Ryoho. 2002 May;29(5):751-6. Gan To Kagaku Ryoho. 2002. PMID: 12040679 Clinical Trial. Japanese.

8

Thrombocytosis as a useful prognostic indicator in patients with lung cancer.

Aoe K, Hiraki A, Ueoka H, Kiura K, Tabata M, Tanaka M, Tanimoto M. Aoe K, et al. Respiration. 2004 Mar-Apr;71(2):170-3. doi: 10.1159/000076679. Respiration. 2004. PMID: 15031573

9

High frequency of allele-specific down-regulation of HLA class I expression in lung cancer cell lines.

Hiraki A, Fujii N, Murakami T, Kiura K, Aoe K, Yamane H, Masuda K, Maeda T, Sugi K, Darzynkiewicz Z, Tanimoto M, Harada M. Hiraki A, et al. Among authors: aoe k. Anticancer Res. 2004 May-Jun;24(3a):1525-8. Anticancer Res. 2004. PMID: 15274319 Free article.

10

Cisplatin down-regulates topoisomerase I activity in lung cancer cell lines.

Aoe K, Kiura K, Ueoka H, Tabata M, Chikamori M, Kohara H, Harada M, Tanimoto M. Aoe K, et al. Anticancer Res. 2004 Nov-Dec;24(6):3893-7. Anticancer Res. 2004. PMID: 15736428 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

158 results

Search Page

Filters